In India, the Securities and Exchange Board of India (SEBI) regulates corporate governance for listed

companies through SEBI (listing obligation and disclosure requirements) regulation 2015 (listing
regulations).

Dr. Reddy’s is in full compliance with all the application provision of SEBI’s corporate governance norms.
It is also in compliance with the appropriate corporate governance standards of the New York Stock
Exchange Inc. (NYSE).

Dr. Reddy’s report on corporate governance for 2017-18 (or FY2018)

Board of Directors:-

Composition:-

As on 31st March 2018, the board of Dr. Reddy’s had 10 directors, comprising

1- Two executive Directors including the chairman of the board.

2- Eight free executives as characterized by the Companies Act, 2013, the Listing Regulations and
Corporate Governance Guidelines of the NYSE Listed Company Manual.

The executives have ability in the field of methodology, the board, account, tasks, science, and innovation,
human asset improvement and financial matters.

Term of Board Membership:-

The board on proposals of the assignment, administration and the remuneration council considers the
arrangement and reappointment of the Director.

Segment 149(10) of the Companies Act, 2013, gives that a free executive will hold office up to 5 back to
back a very long time on the leading body of an organization and will be qualified for reappointment on
the death of an uncommon goals by the investors. In addition, free directors can't resign by rotation.

Accordingly, all independent directors of Dr. Reddy’s were appointed as such for terms ranging from one
to five years at the 30th annual general meeting of the company.

Meeting of the board-:

The company plan and prepares the schedule of board committee meeting for 18 to 24 months in advance.

Under Indian law the board of directors must meet at least 4 times a year with a maximum gap of 120 days
between two board meetings Dr. Reddy’s board meeting 5 times during financial year.

Under Review-
  Attended one meeting though Tele- Conference.
 Attended two meetings though Tele- Conference.

Director’s Shareholding in the company:-

APS trust own 83.11% of Dr. Reddy’s holding limited, which is turn owns 41,083,500 shares of Dr.
Reddy’s laboratories limited.

Shareholders:-

Management:-

The administration of Dr. Reddy's creates and actualizes approaches, techniques, and practices that
endeavor to interpret the organization's center reason and crucial reality. It additionally identiþ es,
measures screens and limits chances in the business and guarantees protected, sound and efþ customer
activity. These are inside administered and observed through the organization's administration
committee (MC).

Management council (MC)

 The companies long haul procedure, development activities, and needs.

 By and large company execution, including those of different specialty units.
 The choice on major corporate approaches.
 Discourse and approve yearly plans, spending plans, speculations and other significant activities.
 Discussion on business alliances proposals and organizational design.

Corporate Social Responsibility:-

 Dr. Reddy’s Laboratories spends 2.05% on CSR.

 This represents a Profit after tax (PAT) margin of 6.9% revenues in FY2018.

Conclusion- As per the data and clarifications are given to us, we are of the supposition that the
organization has conformed to the states of corporate administration as stipulated in the Listing
Regulations, as relevant for the year finished 31 March 2018.